MedPath

PICO- Single-use Negative Pressure Wound Therapy System

Not Applicable
Recruiting
Conditions
Total Ankle Arthroplasty
Registration Number
NCT05064696
Lead Sponsor
Walter C Hembree
Brief Summary

To compare the rate of wound complications with the PICO dressing versus a standard nonstick gauze dressing in patients undergoing anterior total ankle arthroplasty.

Detailed Description

Participating subjects will be randomized to one of the study groups: Group 1 (Control group) or Group 2 (Treatment group). If randomized to Group 1- after surgery, the doctor will apply the standard non-stick gauze dressing to the wound. If randomized to Group 2- after surgery, the doctor will apply the PICO dressing to the wound.

The goal of the study is to measure the rate of wound complications based on wound assessment, patient-reported outcomes surveys, as well as peri- and post-operative data.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria
  • Patient ≥18 years old
  • Subjects undergoing total ankle arthroplasty or uncomplicated revision total ankle arthroplasty
  • Subjects able to provide informed consent
  • Subjects who are able to understand and comply with study visit schedule and procedures
Exclusion Criteria
  • History of previous deep infection or history of wound complication necessitating plastic surgery intervention
  • Allergy to products used in the study
  • Pregnant and breastfeeding women due to anesthesia risks
  • Subjects with a known history of poor compliance with medical treatment
  • Subjects who decline participation in this research study
  • Prisoners

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Wound complicationsApproximately 12-weeks after surgery (or until 3-month postop visit is completed)

To determine presence or absence of wound complications at the follow-up visits.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Amy Loveland

🇺🇸

Baltimore, Maryland, United States

Amy Loveland
🇺🇸Baltimore, Maryland, United States
Amy Loveland
Contact
301-560-2937
amy.loveland@medstar.net
Crisanto Macaraeg
Contact
410-261-8218
Crisanto.L.Macaraeg@Medstar.net
Walter C. Hembree, MD
Principal Investigator
Stuart Miller, MD
Sub Investigator
Gregory Guyton, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.